• Celgene Corporation (CELG) Revlimid Growth Plans Stopped Dead; Stock Plummets More...

• FDA Says Pozen, Inc. (POZN) Ulcer Drug May Need More Data, Shares Plunge More...

• FDA Panel Rejects Sanofi (France) (SAN.PA) Clotting Drug for Chemo Patients More...

• Gentium S.p.A. Submits Day 180 Response to List of Outstanding Issues Received From the EMA's CHMP for Defibrotide MAA More...

• Pfizer Inc. (PFE)'s Lyrica Gains U.S. Approval for Spinal Pain More...

• Chelsea Therapeutics, Inc. (CHTP) Release: Combined Northera™ (droxidopa) Data From Two Phase 3 Trials Confirm Symptom Improvement in Patients With Neurogenic OH More...

• Iroko Pharmaceuticals Release: Novel, Submicron Particle, Lower-Dose Diclofenac Demonstrated Relief of Acute Pain in Phase 3 Study More...

• StemCells Inc. (STEM) Initiates Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration More...

• AEterna Zentaris (AEZS): Phase 1 Results Show Perifosine's Activity Against Neuroblastoma More...

• Cleveland Biolabs Inc. (CBLI) and Incuron Announce Results of Studies of CBL0137 in Animal Models of Neuroblastoma More...

• Robust Octogenarians' Genes Seen Holding Secrets to Aging, Scripps Translational Science Institute Study More...

• What Motivates Generosity? Researchers Study Muslims and Catholics,Arizona State University Study More...

• Healthy Muscle Mass Linked to Healthy Bones, But There are Gender Differences, Mayo Clinic Study More...

• Adolescents Who Have More Than 4 Meals a Day are Thinner, Spanish National Research Council Study More...

• American Heart Association Release:Three Therapies May Reverse Action of New Blood-Thinning Drug More...

• To Kill a Drug Company, Reorganize It More...

• Healthpoint Biotherapeutics Plans $60 Million Expansion; 50 New Jobs to be Created More...

• Glythera Relocates to North East as Part of £2M Funding Round More...

• Merck & Co., Inc. (MRK) in Talks to Buy Indian API Maker More...

• Cannabis Science Inc. Provides Update on Its "Trimcare Brand" Acquisition More...

• ePharmaSolutions to Acquire Global Patient Recruitment Firm Polaris BioPharma More...

• Apricus Biosciences (APRI) to Own Revenue Generating Leading French Drug Sales & Marketing Company More...

• GlaxoSmithKline (GSK) Strikes Collaboration Deal With University of North Carolina Spinoff More...

• Bayer Technology Services and Intergraph® Signed Agreement That Lays the Foundation for a German Partner Community More...

• uniQure Collaborates with University of California, San Francisco (UCSF) on GDNF Gene Therapy in Parkinson's Disease More...

• Bend Research and Catalent Pharma Solutions Partner to Provide Integrated Solutions for Oral Controlled-Release Technologies More...

• Oncolytics Biotech Inc. (ONC.TO) Enters into Sponsorship Agreement with NCIC CTG for Randomized Phase II Study in Advanced and Metastatic Breast Cancers More...

• Clarus Therapeutics Appoints Bela S. Denes, M.D. as Chief Medical Officer More...

• Codexis, Inc. (CDXS) Announces Chief Business Officer Departure More...

• Nile Therapeutics, Inc. Appoints Darlene Horton, M.D., as Chief Medical Officer More...

• Amicus Therapeutics, Inc. (FOLD) Appoints Robert Essner to Board of Directors More...

• Proposal from the Nomination Committee in DiaGenic ASA More...

• Johnson & Johnson (JNJ) Close to Settling Off-Label Probes More...

• TherapeuticsMD, Inc. Files for Two Additional Patents on Prescription Products for Treatment of Menopausal Symptoms & Related Conditions More...

• Centers for Disease Control and Prevention (CDC) Recommends Pfizer Inc. (PFE)'s Prevnar for Immune-Weakened Adults More...

• European Medicines Agency Clears Roche (RHHBY) Cancer Drug MabThera More...

• Cell Therapeutics, Inc. (CTIC) Readies Commercial Launch of Pixuvri® in EU; Re-Alignment of Resources and Portfolio Priorities Reduces Burn Rate by More Than 30% More...

• Nouveau Life Pharmaceuticals (NOUV) Releases Azul Instant&#0153 More...